News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
151 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Biotech Beach
New App-Driven Device from Oska Pulse: “Oska Pulse Active”
Oska Pulse Active App and device will be available to consumers Spring, 2018.
January 9, 2018
·
5 min read
Policy
InflaRx Receives IND Acceptance To Proceed With A Phase IIb Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa
The open IND will allow InflaRx to conduct a phase IIb study to determine efficacy and safety of IFX-1, a first-in-class anti-human complement factor C5a antibody, in patients with moderate or severe Hidradenitis Suppurativa.
January 9, 2018
·
4 min read
BioProtect Launches an International Multi-Center Clinical Study Following FDA IDE
The trial is a prospective, randomized study to demonstrate the safety and efficacy of the ProSpace biodegradable spacer to protect the rectum and lower GI tract during radiation therapy for prostate cancer compared to patients without any spacers.
January 9, 2018
·
2 min read
Genetown
Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds
The U.S. patent will not expire until after 2033.
January 9, 2018
·
1 min read
Genetown
Broad Institute Releases Open-Source GATK4 Software for Genome Analysis, Optimized for Speed and Scalability
Today the Broad Institute of MIT and Harvard is releasing version 4.0 of the Genome Analysis Toolkit, the institute’s flagship genome variant discovery package for analysis of high-throughput sequencing data.
January 9, 2018
·
7 min read
Business
Two Pore Guys and Maxim Integrated Announce Technology Collaboration and Investment
As part of this collaboration, Maxim has invested in 2PG through its venture arm Maxim Ventures.
January 9, 2018
·
4 min read
FDA
IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System
The IlluminOss System incorporates the use of a thin-walled PET balloon that is infused with a liquid monomer and delivered in a minimally invasive fashion into the intramedullary canal of the bone through a small incision.
January 9, 2018
·
3 min read
Business
BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab
Tislelizumab will be manufactured in Boehringer Ingelheim’s world-class biopharmaceutical manufacturing facility in Shanghai.
January 9, 2018
·
6 min read
Business
Histogenics Corporation Announces Receipt of $10M Up-front Payment for Japanese Neocart Agreement
Histogenics and MEDINET announced entering into the agreement in December 2017.
January 9, 2018
·
5 min read
Genetown
BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
BC Platforms today announces that Amgen Finland will be using its technology solutions and research platform, including BCRQUEST.COM.
January 9, 2018
·
2 min read
Previous
7 of 16
Next